Saturday, October 11, 2014

And he was right...


Monday, September 29, 2014

Iressa. Game over. Targeted failure of AstraZeneca

MADRID, Sept 28 (Reuters) - Continuing to give AstraZeneca's drug Iressa plus chemotherapy to lung cancer patents whose disease has worsened after previously taking the medicine on its own does not provide any benefit.
Some doctors had hoped that extending the use of Iressa in combination with chemotherapy would help to keep cancers at bay, even when tumour cells had started to develop resistance to the drug.
But a clinical study presented at the European Society for Medical Oncology annual congress on Sunday found no statistically significant improvement in the length of time patients lived without their disease getting worse.
The Phase III study, involving 265 patients, tested Iressa plus chemotherapy to chemotherapy alone. It was sponsored by AstraZeneca.
http://news.yahoo.com/no-benefit-continued-astrazenecas-iressa-065959911.html

Thursday, September 25, 2014

Quote of the day. Drug development in post-modern

The R&D infrastructure for drug development is shrinking, perhaps irreversibly, and our ability to discover and develop new medicines is being progressively dismantled.

http://medicalxpress.com/news/2014-09-drugs-fundamentally-future.html

Monday, September 22, 2014

Is Peter Thiel a communist? Quote of the day.

You have to think of companies like Microsoft or Oracle or Hewlett-Packard as fundamentally bets against technology. They keep throwing off profits as long as nothing changes. Microsoft was a technology company in the ’80s and ’90s; in this decade you invest because you’re betting on the world not changing. Pharma companies are bets against innovation because they’re mostly just figuring out ways to extend the lifetime of patents and block small companies.

http://pipeline.corante.com/archives/2014/09/19/peter_thiels_uncomplimentary_views_of_big_pharma.php